Ingenii
Ingenii is a quantum machine learning company offering educational courses, the open-source ingenii-quantum Python library, the Ingenii Exchange validation platform, and applied research services focused on drug discovery, medical imaging, biomarker discovery, and clinical trial optimization for healthcare and life sciences organizations.
- Company typePrivate
- Founded2021
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Ingenii does
Ingenii Inc. is a New York-based quantum machine learning (QML) company founded in 2021 by Christine Johnson (CEO) and Dr. Laia Domingo (CSO). It operates a "Quantum Hub" that bundles three layers: (1) educational pathways (self-paced QML courses, the EQIP 12-week immersion program, and enterprise professional training), (2) tooling including the open-source ingenii-quantum Python library and the Ingenii Exchange use-case validation platform, and (3) applied research and enablement services focused on life-sciences verticals — drug discovery, medical imaging, biomarker discovery, and clinical trial optimization. The proprietary technology centers on hybrid quantum-classical algorithms, quantum-inspired optimization, and evaluation metrics (e.g., entangling capacity, expressibility), with claimed performance advantages including >100x computational efficiency in patient stratification, 75-90% GPU resource reduction, and 2x faster training times for medical imaging models.
The company monetizes through a freemium subscription model for individual learners ($19.99/month for Fundamentals, $29.99/month All Access Bundle or Exchange Premium), a one-time $1,499 fee for the EQIP cohort-based program (limited to 20 seats), and enterprise sales for professional training and QML enablement consulting/POC development. Customer segments span aspiring quantum professionals, data-science teams in pharma/biotech/medtech/CROs, accelerators, and strategy/innovation leaders. The firm holds no patents and has disclosed only ~$100,882 in funding (May 2023), and no external venture capital is on record. Recognition includes the 2024 NIH Quantum Computing Challenge win, selection to Duality Accelerator Cohort 3 (2023), and academic partnerships with Purdue, University of Chicago, Chicago Quantum Exchange, and Memorial Sloan Kettering Cancer Center.
Ingenii serves a global community of 1,200+ students, scientists, and industry professionals through digital self-serve channels for individuals and direct enterprise sales for organizational clients, with cloud infrastructure spanning Microsoft Azure, AWS, Google Cloud, and Databricks.
Ingenii firmographics
Firmographics- Name
- Ingenii
- Legal name
- Ingenii Inc.
- Website
- https://ingenii.io
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Ingenii is a quantum machine learning company offering educational courses, the open-source ingenii-quantum Python library, the Ingenii Exchange validation platform, and applied research services focused on drug discovery, medical imaging, biomarker discovery, and clinical trial optimization for healthcare and life sciences organizations.
- Ownership category
- akta.pro rank
Ingenii industry classification
Industry- Product category
- Quantum Machine Learning Software
- NAICS
- Computer Training (611420), Computer Systems Design Services (541512), Educational Support Services (611710)
- SIC
- Services-Computer Programming Services (7371), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Quantum Education & Certification Programs (HDAGALAA)
- akta.pro secondary industries
- Quantum Documentation, Education SDKs & Developer Enablement Tools (HDAGACAN), Quantum Consulting & Strategy Advisory (HDAGALAC), Quantum Software Engineering & Toolchain Training (HDAGALAF)
Keywords
Where Ingenii is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Ingenii business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- QML Course Subscriptions: Self-paced online courses with free basic access and premium paid tiers ($19.99-$29.99/month or bundle pricing). Includes QML Fundamentals and Imaging Analysis courses with certifications.
- EQIP Program: 12-week immersive quantum machine learning program priced at $1499 for the full experience. Limited cohort of 20 seats with early bird discounts available.
- Professional Training Programs: Customized training programs for enterprise data science and innovation teams. Programs include 1-day, 3-day, and custom curriculum options with premium course licenses included.
- Ingenii Exchange Premium: Subscription-based platform access at $29.99/month for premium features including unlimited technical assessments, private use cases, community projects, and direct messaging.
- QML Enablement Services: Consulting and POC development services for organizations to identify quantum ML use cases and develop tailored solutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free QML Fundamentals Course |
| Subscription | Monthly | QML Fundamentals Premium - $19.99 |
| Subscription | Monthly | QML for Imaging Analysis Premium |
| Subscription | Monthly | All Access Bundle - $29.99 |
| One time/ perpetual license | Multi-year contract | EQIP 12-Week Program - $1499 |
| Unit Pricing | Multi-year contract | Professional Training Programs |
| Freemium | Monthly | Ingenii Exchange - Free Tier |
| Subscription | Monthly | Ingenii Exchange Premium - $29.99/month |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels9 records
Ingenii product offering
Product offeringCore offering
Ingenii provides a quantum machine learning platform that combines self-paced QML courses, an open-source Python library (ingenii-quantum), a community validation platform (Ingenii Exchange), and applied research services targeting healthcare and life sciences use cases such as drug discovery, medical imaging, clinical trials, and biomarker discovery. The company also delivers enterprise training programs and consulting services that help data science teams prototype quantum and quantum-inspired ML solutions before committing to R&D investment.
Product overview
Ingenii offers a unified Quantum Hub platform combining educational courses (QML Fundamentals, Imaging Analysis, EQIP immersive program), research tools, and the open-source ingenii-quantum Python library for quantum ML development. The portfolio includes specialized platforms: Ingenii Exchange for use case validation, Translational Signal Intelligence (TSI) for drug development signal extraction, and QML Enablement Services for custom solutions. Research applications span Quantum Drug Discovery, Quantum Clinical Trials, Quantum Medical Imaging, and Quantum Biomarker Discovery.
Differentiator
Problem solved
Functional benefit
Products and services
- Quantum Hub
Quantifiable outcome
- 20% saving in training parameters for drug binding affinity prediction
- +10 more outcomes
Companies that use Ingenii
Customer profileNamed customers3 records
Segments7 records
Ideal customer profiles5 records
Ingenii technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature8 records
Ingenii partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered flagship, core and supporting.
- Duality AcceleratorflagshipIngenii is one of four startups selected for Duality Accelerator Cohort 3. Duality is led by the Polsky Center for Entrepreneurship and Innovation at the University of Chicago and the Chicago Quantum Exchange, along with founding partners University of Illinois Urbana-Champaign, Argonne National Laboratory, and P33. The 12-month program provides world-class business and entrepreneurship training from partner institutions and the University of Chicago Booth School of Business.
- Purdue Data MinecoreIngenii CSO Laia Domingo is collaborating with Purdue Data Mine on improving the speed and accuracy of cancer precision therapy using quantum computing and QML models that consider both molecule and protein interactions at the proteomic level and patient data.
- University of ChicagocorePartner institution through Duality Accelerator and Chicago Quantum Exchange consortium, providing academic collaboration and entrepreneurship support for quantum technology development.
- Chicago Quantum Exchange (CQE)coreConsortium partner supporting quantum technology research and development through the Duality Accelerator program, connecting quantum startups with leading research institutions.
- Microsoft AzuresupportingCloud computing partner providing infrastructure support for Ingenii's quantum ML platform and research operations.
- Google CloudsupportingData partner providing cloud infrastructure and data processing capabilities for Ingenii's quantum ML research and platform operations.
- AWS (Amazon Web Services)supportingCloud infrastructure partner supporting quantum ML research and computational needs for Ingenii's platform and services.
- DatabrickssupportingData analytics partner providing data engineering and processing capabilities for quantum ML research and analysis workflows.
- Purdue UniversitycoreAcademic partner hosting the NSF Center for Quantum Technologies where Dr. Sabre Kais serves as Center Director. Multiple collaborations including Quantum Technology education through MicroMasters program.
- NSF Center of Quantum TechnologiessupportingNational Science Foundation-funded research center focused on advancing quantum science and technology, with Dr. Sabre Kais serving as Center Director.
- Creators League Duality (CLD)supportingInnovation partner through the Duality Accelerator ecosystem, supporting quantum technology startup development and commercialization.
- Memorial Sloan Kettering Cancer Center (MSKCC)supportingDr. Alexander Stevens serves as advisor for oncology applications, providing expertise in AI/ML for healthcare and developing ethical AI frameworks (TrAAIT, FASTER) for trustworthy AI in cancer care.
Scale indicators3 records
Recent moves6 records
Expansion highlights7 records
Ingenii competitors and assessment
Company assessmentDirect peers
- Xanadu: Xanadu builds PennyLane, a widely adopted open-source QML framework, and offers quantum computing hardware and enterprise software. Comparable to Ingenii because both operate open-source QML libraries with developer-focused tooling, education programs, and applied research into life sciences and chemistry use cases.
- Classiq: Classiq provides a quantum software development platform focused on algorithm synthesis and enterprise deployment. Comparable to Ingenii for its developer-tool positioning in quantum and its enterprise services motion, though it focuses more broadly than life sciences.
- Multiverse Computing: Multiverse Computing applies quantum and quantum-inspired algorithms to finance, life sciences, and manufacturing. Comparable to Ingenii for its emphasis on quantum-inspired methods that run on classical hardware, vertical specialization, and enterprise POC-led go-to-market.
- Zapata AI: Zapata AI (formerly Zapata Computing) builds an enterprise quantum-inspired and quantum ML platform for optimization and generative modeling in life sciences and logistics. Comparable to Ingenii in combining QML, optimization, and enterprise services targeting pharma and similar verticals.
- QC Ware: QC Ware develops enterprise quantum software with a focus on life sciences, chemistry, and optimization, offering both SaaS and services. Directly comparable to Ingenii in delivering QML and optimization tools alongside enterprise enablement and customer pilots.
- QunaSys: QunaSys provides quantum chemistry and QML software for pharmaceutical and materials science customers. Directly comparable to Ingenii for its vertical focus on life sciences/chemistry, applied research output, and enterprise software positioning around near-term quantum advantage.
- Strangeworks: Strangeworks is a quantum computing platform offering developer access to multiple quantum hardware backends, education content, and enterprise tools. Comparable to Ingenii for its developer/education focus and platform-style monetization around quantum tooling.
Broad incumbents
- Quantinuum: Quantinuum is a full-stack quantum computing company combining trapped-ion hardware with software, including QML capabilities. Comparable to Ingenii as a broad incumbent operating across hardware, software, and applied QML research rather than as a focused life-sciences education and tooling startup.
- 1QBit: 1QBit develops quantum and quantum-inspired software for life sciences, advanced materials, and optimization. Comparable to Ingenii as a broader incumbent that historically focused on enterprise QML and optimization services with deep life sciences engagements.
- IBM Quantum: IBM Quantum offers the Qiskit framework with extensive learning resources, certification programs, and enterprise access to quantum hardware. Comparable to Ingenii as a broad incumbent operating quantum education programs and developer tools that compete for the same aspiring quantum professional audience.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Ingenii social profiles
Digital presenceIngenii financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ingenii leadership team
Management profileNumber of profiles
Profiles7 records
Ingenii funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ingenii M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ingenii
What does Ingenii do?
Ingenii provides a quantum machine learning platform that combines self-paced QML courses, an open-source Python library (ingenii-quantum), a community validation platform (Ingenii Exchange), and applied research services targeting healthcare and life sciences use cases such as drug discovery, medical imaging, clinical trials, and biomarker discovery. The company also delivers enterprise training programs and consulting services that help data science teams prototype quantum and quantum-inspired ML solutions before committing to R&D investment.
Is Ingenii a public or private company?
Ingenii is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ingenii founded?
Ingenii was founded in 2021. It employs 1 to 10 people.
Where is Ingenii based?
Ingenii is headquartered in New York, United States, in the North America region.
How does Ingenii make money?
Five revenue lines are on record. QML Course Subscriptions are the primary driver. The others are EQIP Program, professional Training Programs, ingenii Exchange Premium and QML Enablement Services.
Who are Ingenii's main competitors?
Direct peers on record are Xanadu, Classiq, Multiverse Computing, Zapata AI, QC Ware, QunaSys and Strangeworks. Broad incumbents are Quantinuum, 1QBit and IBM Quantum.
Does Ingenii have an API?
No public API is recorded for Ingenii.
What industry is Ingenii in?
Ingenii's product category is Quantum Machine Learning Software. Its primary akta.pro industry code is HDAGALAA, Quantum Education & Certification Programs, with a secondary code of HDAGACAN, Quantum Documentation, Education SDKs & Developer Enablement Tools. Its NAICS code is 611420 and its SIC code is 7371.